Archived Session: “Guidelines for Management of Hyperbilirubinemia in Newborn Infants (35 or More Weeks of Gestation)” with Alex Kemper, MD, MPH, MS, FAAP and Thomas Newman, MD, MPH, FAAP
June 27, 2023
View a recording of this session below ↓
Drs Alex Kemper and Thomas Newman present on guidelines for management of hyperbilirubinemia in newborn infants (35 or more weeks of gestation), based on the clinical practice guidelines published in Pediatrics, which are featured in several First 1,000 Days learning modules. Drs Kemper and Newman provide a brief summary of key recommendations in the 2022 guideline and address some of the most frequently asked questions about it.
Alex Kemper, MD, MPH, MS, FAAP is the Division Chief of Primary Care Pediatrics at Nationwide Children’s Hospital and Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Kemper completed his pediatric residency training at Duke University followed by combined fellowship training in health services research and medical informatics with residency training in preventive medicine at the University of North Carolina. His research focuses of a wide range of preventive services. Dr. Kemper is a former member of the US Preventive Services Task Force. He serves as the Chair of the Condition Review Workgroup for the U.S. Secretary of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children. Dr. Kemper is also the Deputy Editor of Pediatrics.
Thomas Newman, MD, MPH, FAAP is Professor Emeritus of Epidemiology & Biostatistics and Pediatrics at UCSF. Dr. Newman uses methods of epidemiology to do research on clinical problems in pediatrics, such as jaundice and infections in newborn babies, urinary tract infections and cholesterol screening. He has a long term interest in teaching clinical research methods and is coauthor of two textbooks: Designing Clinical Research (5th edition, with Warren Browner and others, 2022) and Evidence-Based Diagnosis (2nd edition, with Dr. Michael Kohn, 2020).
